Unfortunately the meeting highlights from this week's CHMP meeting provide no insight into where VG stands. The only possible references are these:
"The Committee accepted 36 new Requests.....2 Qualification of novel methodologies" AND/OR under "Other Updates" - "Opinions on consultation procedures on ancillary medicinal substances in medical devices"
So I guess we wait for formal communication from EMA to BSI to TIS.
Rev
Unfortunately the meeting highlights from this week's CHMP...
Add to My Watchlist
What is My Watchlist?